Alignment Healthcare, Inc. (NASDAQ:ALHC) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have earned a consensus recommendation of “Moderate Buy” from the twelve research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokers that have covered the stock in the last year is $24.5556.

Several research firms recently issued reports on ALHC. UBS Group increased their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 14th. Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, March 7th. Piper Sandler upped their target price on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 6th. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a report on Friday, January 30th. Finally, JPMorgan Chase & Co. lifted their price target on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th.

Alignment Healthcare Trading Down 0.5%

ALHC opened at $17.42 on Wednesday. Alignment Healthcare has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a 50-day simple moving average of $20.30 and a 200 day simple moving average of $18.84. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. The stock has a market capitalization of $3.56 billion, a price-to-earnings ratio of -1,740.26, a P/E/G ratio of 2.56 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.10. The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The business’s quarterly revenue was up 44.4% compared to the same quarter last year. During the same period last year, the firm earned ($0.16) EPS. Analysts predict that Alignment Healthcare will post -0.69 EPS for the current fiscal year.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, COO Sebastian Burzacchi sold 15,361 shares of the business’s stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total transaction of $274,040.24. Following the completion of the transaction, the chief operating officer owned 258,630 shares of the company’s stock, valued at approximately $4,613,959.20. The trade was a 5.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Andreas P. Wagner sold 11,602 shares of the stock in a transaction dated Thursday, March 19th. The stock was sold at an average price of $18.22, for a total transaction of $211,388.44. Following the completion of the transaction, the insider directly owned 148,628 shares of the company’s stock, valued at $2,708,002.16. This trade represents a 7.24% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 2,418,393 shares of company stock worth $46,473,667 over the last quarter. 6.60% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Alignment Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in ALHC. Summit Securities Group LLC bought a new position in shares of Alignment Healthcare during the fourth quarter valued at $26,000. Parallel Advisors LLC lifted its holdings in shares of Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares during the period. Larson Financial Group LLC bought a new stake in shares of Alignment Healthcare in the third quarter worth $33,000. First Horizon Corp acquired a new stake in Alignment Healthcare in the fourth quarter valued at $39,000. Finally, GAMMA Investing LLC increased its holdings in Alignment Healthcare by 83.8% in the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after purchasing an additional 987 shares during the period. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.